What's on this Page
Nystatin and Triamcinolone Brand Names
Mycogen-II | Mycolog II | Myco-Triacet-II | Mytrex | N.T.A. | Viaderm KC
What is Nystatin and Triamcinolone
Nystatin and triamcinolone are used together in a topical preparation for short-term (i.e., less than 2 weeks) treatment of candidal skin infections.
Nystatin is an antifungal agent and triamcinolone is a corticosteroid used for its antiinflammatory, vasoconstrictive, and antipruritic properties.
Compared to nystatin or triamcinolone alone, the combination has been shown to provide faster and more pronounced clearing of erythema and pruritus, especially in the first few days of treatment.
Nystatin and triamcinolone was approved by the FDA in May 1985.
Indications
- Candida albicans
- Candida sp.
- candidiasis
Side Effects
- acneiform rash
- contact dermatitis
- Cushing’s syndrome
- folliculitis
- glycosuria
- hyperglycemia
- hypertrichosis
- hypothalamic-pituitary-adrenal (HPA) suppression
- increased intracranial pressure
- infection
- miliaria
- pruritus
- skin atrophy
- skin hypopigmentation
- skin irritation
- striae
- superinfection
- xerosis
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- benzyl alcohol hypersensitivity
- breast-feeding
- children
- corticosteroid hypersensitivity
- Cushing’s syndrome
- geriatric
- hypothalamic-pituitary-adrenal (HPA) suppression
- infants
- occlusive dressing
- ocular exposure
- peripheral vascular disease
- pregnancy
- skin abrasion
- skin atrophy
Interactions
There are no drug interactions associated with Nystatin and Triamcinolone products.